Lv2
170 积分 2025-11-19 加入
Lessons learned in linking PROTACs from discovery to the clinic
9天前
已完结
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
1个月前
已完结
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease
1个月前
已完结